Polychemotherapy

Plasma cell leukemia

Plasma
Plasma cell leukemia (PCL), a lymphoproliferative disorder, is a rare cancer involving a subtype of white blood cells called plasma cells. Plasma cell leukemia is one of the most aggressive human neoplasms and constitutes 2% to 4% of all cases of plasma cell disorders. The WHO criterion for diagnosis of PCL is that plasma cells constitute more than 20% of cells in the peripheral blood with an absolute plasma cell count of more than 2 × 10/L. The presentation may be primary, de novo, or secondary, evolving from an existing case of multiple myeloma as part of the terminal phase of the disease...

Polychemotherapy - List of case studies

Rectal Carcinoma, Gastric Carcinoma, Metastases.

2) Polychemotherapy : this is advocated if the option of intraperitoneal ... etc. 3) Targeted biotherapy combined with polychemotherapy : In view of the limited benefit offered by ... available and well known biological agents to the chosen polychemotherapy regimen . I admit that such combinations are expensive and ...

Ovarian Cancer with Metastases

prior to this report, the patient had 8 cycles of polychemotherapy with Caelyx-Oxaliplatin, achieving clinical and ... uterus, adenexae, onsectonomy, adjuvant chemotherapy, polychemotherapy,     ...

Drugs

pumps Pneumococcal vaccine Polase Polychemotherapy Polyvitamins Pomalidomide Postpone ...

Inflammatory Demyelinizing Disease

with associated systemic symptomatology (stage II B). A polychemotherapy treatment was performed according to the ABVD protocol (4 ... acetate (GA).   Treatments : polychemotherapy treatment (according to the ABVD protocol), radiotherapeutic ...

JustAnswer.com